"I want to share my story and help others like myself living with MPN. MPN Research Foundation has been that source of community support for my family and I as we learn to deal with living with a disease on a daily basis."

News

Help me find

YM Biosciences meets safety requirements; recruiting more patients

YM Biosciences has been working with YM Biosciences Australia (formerly Cytopia) on testing the JAK2 Inhibitor CYT387 in myelofibrosis patients. Enrollment for this trial ended in November 2009 and the trial is on pace to be completed 6 months ahead of the original deadline of the second half of 2011.

Click here to read the press release (you will be redirected).

 

Your donation goes a long way.

Learn more about how you can help support the MPN Research Foundation and the impact your contributions can make.

Donate Now
 
 
 

Subscribe

Want to learn more about the MPN Research Foundation? Sign up for our Newsletter and Research Alerts!

Newsletter Signup

 
 

Connect with Us

MPN Research Foundation wants to hear from you. Connect with us through our social networks or send us an email.

Email Facebook Twitter LinkedIn